G01N 2333/66
Thymopoietins
G01N2333/66 (Thymopoietins) appears on 5 US grants and 2 published applications in this corpus.
Search patents in G01N- Granted patents
- 5
- Published applications
- 2
- Assignees
- 3
- Inventors
- 6
- Latest grant
- 6 Feb 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Cell analysis using dynamic biophysical methods6 Feb 2018US 9,885,705 B2Bar-Ilan University
- Method and compositions for making ACSF and ACSF antagonists9 Jun 1998US 5,763,195 AGenentech, Inc.
- Method and compositions for making ACSF and ACSF antagonists16 Sep 1997US 5,668,106 AGenentech, Inc.
- Method and compositions for making ACSF and ACSF antagonists12 Aug 1997US 5,656,455 AThe University of Melbourne
- Method and compositions for making ACSF and ACSF antagonists17 May 1994US 5,312,810 AGenentech, Inc.
Most cited
By later US patents